Skeletal Myopathy in Systemic Sclerosis Associated with Higher Disease Burden and Mortality

Occasionally, patients with scleroderma also have or develop skeletal myopathies. Rheumatologist Julie Paik explains her recent study findings that these comorbidities lead to increase disease burdens and morbidity.

Related Presenters

Julie Paik, MD.

Julie Paik, MD

Director of Clinical Trials at the Johns Hopkins Myositis Center

Dr. Julie Paik completed her medical school training at the George Washington University School of Medicine in Washington, DC. She then completed her residency and chief residency at UCLA-Cedars-Sinai/VA Medical Center in Los Angeles, ...

View full profile


Related Videos